# Antibiotic Prophylaxis in Metabolic Bariatric Surgery

> **NCT06510452** · NA · NOT_YET_RECRUITING · sponsor: **General Committee of Teaching Hospitals and Institutes, Egypt** · enrollment: 3352 (estimated)

## Conditions studied

- Antibiotic Reaction
- Wound Infection Superficial
- Wound Infection Deep
- Bariatric Surgery Candidate
- Complication,Postoperative

## Interventions

- **DRUG:** 2000 mg of Cefazolin
- **DRUG:** 500 mg of Metronidazole IV
- **DRUG:** NACL 0.9% 100 ml

## Key facts

- **NCT ID:** NCT06510452
- **Lead sponsor:** General Committee of Teaching Hospitals and Institutes, Egypt
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-10-01
- **Primary completion:** 2025-12-01
- **Final completion:** 2026-04-01
- **Target enrollment:** 3352 (ESTIMATED)
- **Last updated:** 2024-07-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06510452

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06510452, "Antibiotic Prophylaxis in Metabolic Bariatric Surgery". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06510452. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*